[1] Palucka AK, Coussens LM. The basis of oncoimmunology[J]. Cell, 2016,164:1233-1247. [2] Ali Z, Vildevall M, Rodriguez GV, et al. Zebrafish mouse-derived xenograft models predict lymph node involvement and treatment outcome in non-small cell lung cancer[J]. J Exp Clin Cancer Res, 2022,41:58.doi:10.1186/s13046-022-02280-x. [3] Chen L, Zhang J, Wang X, et al. Discovery of novel KRAS-PDEδ inhibitors with potent activity in mouse-derived human pancreatic tumor xenograft models[J]. Acta Pharm Sin B, 2022,12:274-290. [4] Moy RH, Walch HS, Mattar M, et al. Defining and targeting esophagogastric cancer genomic subsets with mouse-derived xenografts[J]. JCO Precis Oncol, 2022,6: e2100242. doi:10.1200/PO.21.00242. [5] Yuan Z, Fan X, Zhu JJ, et al. Presence of complete murine viral genome sequences in mouse-derived xenografts[J]. Nat Commun, 2021,12:2031.doi:10.1038/s41467-021-22200-5. [6] Dijkstra KK, Cattaneo CM, Weeber F, et al. Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids[J]. Cell, 2018,174:1586-1598. [7] Zumwalde NA, Haag JD, Sharma D, et al. Analysis of immune cells from human mammary ductal epithelial organoids reveals Vδ2+ T cells that efficiently target breast carcinoma cells in the presence of bisphosphonate[J]. Cancer Prev Res (Phila), 2016,9:305-316. [8] Neal JT, Li X, Zhu J, et al. Organoid modeling of the tumor immune microenvironment[J]. Cell, 2018,175:1972-1988 [9] Vlachogiannis G, Hedayat S, Vatsiou A, et al. Mouse-derived organoids model treatment response of metastatic gastrointestinal cancers[J]. Science, 2018,359:920-926. [10] Sachs N, de Ligt J, Kopper O, et al. A living biobank of breast cancer organoids captures disease heterogeneity[J]. Cell, 2018,172:373-386. [11] Pauli C, Hopkins BD, Prandi D, et al. Personalized in vitro and in vivo cancer models to guide precision medicine[J]. Cancer Discov, 2017,7:462-477. [12] Fujii M, Shimokawa M, Date S, et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis[J]. Cell Stem Cell, 2016,18:827-838. [13] Boj SF, Hwang CI, Baker LA, et al. Organoid models of human and mouse ductal pancreatic cancer[J]. Cell, 2015,160:324-338. [14] Hirt C, Papadimitropoulos A, Mele V, et al. “In vitro” 3D models of tumor-immune system interaction[J]. Adv Drug Deliv Rev, 2014,79-80:145-154. |